Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal

Authors: Xinya Li, Zaiwei Song, Yixuan Chen, Jingjing Wu, Dan Jiang, Zhen Zhang, Zeyuan Wang, Rongsheng Zhao

Source: Cancer Immunology, Immunotherapy, Vol 74, Iss 1, Pp 1-20 (2024)

Subject Terms: Immune checkpoint inhibitors, Immune checkpoint inhibitors-related thyroid dysfunction, ICI-TD, Risk prediction model, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1432-0851

Access URL: https://doaj.org/article/4bee2703442546a8b9317d7fd8551598

Development of the implementability assessment tool for clinical practice guidelines based on the COSMIN framework and factorial experiment: a study protocol

Authors: Dongmei Zhong, Gregory A Aarons, Alison M Hutchinson, Zhaolan Liu, Yaolong Chen, William CW Wong, Zaiwei Song, Yanni Wu, Lijiao Yan, David Makram Bishai, Nan Yang, Zijun Wang, Hui Liu, Dong (Roman) Xu

Source: BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)

Subject Terms: Implementability, Clinical practice guidelines, Implementation study, COSMIN framework, Factorial experiment, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://doaj.org/toc/1472-6963

Access URL: https://doaj.org/article/b7e7ace19be24224b165116d13bf55d4

Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal

Authors: Xinya Li, Zaiwei Song, Yixuan Chen, Jingjing Wu, Dan Jiang, Zhen Zhang, Zeyuan Wang, Rongsheng Zhao

Source: Cancer Immunology, Immunotherapy, Vol 74, Iss 2, Pp 1-2 (2025)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1432-0851

Access URL: https://doaj.org/article/2ed6619f97314f079794fae920dd25b3

Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review

Authors: Xinya Li, Zaiwei Song, Zhanmiao Yi, Jiguang Qin, Dan Jiang, Zhitong Wang, Huibo Li, Rongsheng Zhao

Source: Therapeutic Advances in Medical Oncology, Vol 16 (2024)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1758-8359

Access URL: https://doaj.org/article/f49cd6ea99c94aa5838912ed332ebd43

Osteonecrosis of the jaw induced by immune checkpoint inhibitors: an urgent need for attention

Authors: Xinya Li, Zaiwei Song, Rongsheng Zhao

Source: Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-4 (2023)

Subject Terms: Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1479-5876

Access URL: https://doaj.org/article/1e3ac572143d4ae38bfe89aa54642d31

Toward therapeutic drug monitoring of citalopram in depression? Insights from a systematic review

Authors: Na Xu, Zaiwei Song, Dan Jiang, Rongsheng Zhao

Source: Frontiers in Psychiatry, Vol 14 (2023)

Subject Terms: citalopram, therapeutic drug monitoring, plasma concentration, depression, treatment outcome, Psychiatry, RC435-571

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1144573/full; https://doaj.org/toc/1664-0640

Access URL: https://doaj.org/article/3402789713cd4f719428fe2c4ecec2b1

Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship

Authors: Zaiwei Song, Lan Ma, Li Bao, Yi Ma, Ping Yang, Dan Jiang, Aijun Liu, Lu Zhang, Yan Li, Yinchu Cheng, Fei Dong, Rongsheng Zhao, Hongmei Jing

Source: Frontiers in Pharmacology, Vol 13 (2022)

Subject Terms: lenalidomide, hematological toxicity, therapeutic drug monitoring, trough concentration, hematological malignancies, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2022.931495/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/effc87189acc470dbdce878f50cbb6f6

Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey

Authors: Yang Hu, Zaiwei Song, Dan Jiang, Lin Zhuo, Yinchu Cheng, Rongsheng Zhao

Source: Frontiers in Pharmacology, Vol 13 (2022)

Subject Terms: biosimilars, knowledge, attitudes, practice, China, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2022.876503/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/3d0cfccee13f4c32892baca1db17572f

Long-Term Safety of Rituximab in DLBCL Patients With Hepatitis B-Related Cirrhosis: A Retrospective Case Series

Authors: Zaiwei Song, Yi Ma, Dan Jiang, Rongsheng Zhao, Fei Dong

Source: Frontiers in Medicine, Vol 9 (2022)

Subject Terms: diffuse large B cell lymphoma, cirrhosis, rituximab, hepatitis B virus, reactivation, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2022.890339/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/a320cf8612c14990ad40194ec783e6d7

Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations

Authors: Zaiwei Song, Yang Hu, Zhenyu Ren, Guanru Wang, Shuang Liu, Siqian Zheng, Li Yang, Rongsheng Zhao

Source: Frontiers in Public Health, Vol 9 (2022)

Subject Terms: patient management, pharmaceutical care, pharmacist, coronavirus disease 2019, COVID-19, Public aspects of medicine, RA1-1270

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fpubh.2021.758325/full; https://doaj.org/toc/2296-2565

Access URL: https://doaj.org/article/0e50d77ed431487faf22de9254bee958

The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis

Authors: Zaiwei Song, Yang Hu, Shuang Liu, Dan Jiang, Zhanmiao Yi, Mason M. Benjamin, Rongsheng Zhao

Source: Frontiers in Pharmacology, Vol 12 (2021)

Subject Terms: methotrexate, pharmacogenetics, polymorphism, toxicity, hematological malignancies, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.757464/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/e85d21da46d4467f9a045d98b771ff7c

Using Delphi Method to Determine the Clinical Questions and Outcomes Included the Practice Guideline for Clinical Use of High-dose Methotrexate

Authors: Zaiwei, Song, Zhiyuan, Tan, Youping, Li

Source: Yao wu liu xing bing xue za zhi. 27(2):134-137

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN615155789&indx=1&recIds=ETOCRN615155789

Chinese Practice Guideline for Individualized Medication of Voriconazole: Recommendations External Review

Authors: Ken, Chen, Zaiwei, Song, Wei, Liu

Source: Yao wu liu xing bing xue za zhi. 26(2):143-147

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN610888329&indx=1&recIds=ETOCRN610888329

Ticagrelor in the Treatment of Acute Coronary Syndrome: Health Technology Assessment

Authors: Shujie, Dong, Xiao, Liu, Zaiwei, Song

Source: Yao wu liu xing bing xue za zhi. 26(7):441-445

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN612608100&indx=1&recIds=ETOCRN612608100